Literature DB >> 11861789

NADPH-dependent metabolism of estrone by human liver microsomes.

Anthony J Lee1, Laura H Mills, Joseph W Kosh, Allan H Conney, Bao Ting Zhu.   

Abstract

We characterized the NADPH-dependent metabolism of estrone (E1) by liver microsomes of 21 male and 12 female human subjects. The structures of 11 hydroxylated or keto metabolites of E1 formed by human liver microsomes were identified by chromatographic and mass spectrometric analyses. 2-Hydroxylation of E1 was the dominant metabolic pathway with all human liver microsomes tested. E1 is more prone to form catechol estrogens (particularly 4-OH-E1) than 17beta-estradiol (E2) and the average ratio of E1 4-hydroxylation to 2-hydroxylation (0.24) was slightly higher than the ratio of E2 4- to 2-hydroxylation (0.20, P < 0.001). An unidentified monohydroxylated E1 metabolite (y-OH-E1) was found to be one of the major metabolites formed by human liver microsomes of both genders. 6beta-OH-E1, 16alpha-OH-E1, and 16beta-OH-E1 were also formed in significant quantities. 16alpha-hydroxylation was not a major pathway for E1 metabolism. The overall profiles for the E1 metabolites formed by male and female human liver microsomes were similar, and their average rates were not significantly different. Hepatic CYP3A4/5 activity in both male and female liver microsomes correlated strongly with the rates of formation of several hydroxyestrogen metabolites. The dominant role of hepatic CYP3A4 and CYP3A5 in the formation of these hydroxyestrogen metabolites was further confirmed by incubations of human CYP3A4 or CYP3A5 with [3H]E1 and NADPH. Notably, human CYP3A5 has very high relative activity for E1 4-hydroxylation, exceeding its activity for E1 2-hydroxylation by approximately 100%. It will be of interest to determine the potential biological functions associated with any of the E1 metabolites identified in our present study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861789     DOI: 10.1124/jpet.300.3.838

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability.

Authors:  Roni T Falk; Xia Xu; Larry Keefer; Timothy D Veenstra; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

2.  Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons.

Authors:  Ru Yan; Tatiana N Nanovskaya; Olga L Zharikova; Donald R Mattison; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biochem Pharmacol       Date:  2008-02-07       Impact factor: 5.858

3.  Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes.

Authors:  Jin Sol Lee; Hyun Sub Cheong; Lyoung Hyo Kim; Ji On Kim; Doo Won Seo; Young Hoon Kim; Myeon Woo Chung; Soon Young Han; Hyoung Doo Shin
Journal:  Korean J Physiol Pharmacol       Date:  2013-12-16       Impact factor: 2.016

4.  4-Hydroxyestrone, an Endogenous Estrogen Metabolite, Can Strongly Protect Neuronal Cells Against Oxidative Damage.

Authors:  Hye Joung Choi; Anthony J Lee; Ki Sung Kang; Ji Hoon Song; Bao Ting Zhu
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

5.  Hydroxylation and sulfation of sex steroid hormones in inflammatory liver.

Authors:  Sang R Lee; Seung-Yeon Lee; Sang-Yun Kim; Si-Yun Ryu; Bae-Kuen Park; Eui-Ju Hong
Journal:  J Biomed Res       Date:  2017-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.